This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brooks, W. W. Articles by Boluyt, M. O. Search for Related Content PubMed PubMed Citation Articles by Brooks, W. W. Articles by Boluyt, M. O. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CAPTOPRIL Medline Plus Health Information Heart Failure High Blood Pressure Seniors' Health

(Hypertension. 1997;30:1362-1368.)
© 1997 American Heart Association, Inc.

Articles

Captopril Modifies Gene Expression in Hypertrophied and Failing Hearts of Aged Spontaneously Hypertensive Rats

Wesley W. Brooks; Oscar H. L. Bing; Chester H. Conrad; Lydia O'Neill; Michael T. Crow; Edward G. Lakatta; David E. Dostal; Kenneth M. Baker; ; Marvin O. Boluyt

From the Department of Veterans Affairs Medical Center, Boston, Mass; the Department of Medicine, Boston University School of Medicine, Boston, Mass; the Weis Center for Research, Geisinger Clinic, Danville, Pa; and the Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, National Institutes of Health, Baltimore, Md.

Abstract The spontaneously hypertensive rat (SHR) exhibits a transition from stable compensated left ventricular (LV) hypertrophy to heart failure (HF) at a mean age of 21 months that is characterized by a decrease in -myosin heavy chain (-MHC) gene expression and increases in the expression of the atrial natriuretic factor (ANF), pro-₁(III) collagen, and transforming growth factor ß₁ (TGF-ß₁) genes. We tested the hypotheses that angiotensin-converting enzyme inhibition (ACEI) in SHR would prevent and reverse HF-associated changes in gene expression when administered prior to and after the onset of HF, respectively. We also investigated the effect of ACEI on circulating and cardiac components of the renin-angiotensin system. ACEI (captopril 2 g/L in the drinking water) was initiated at 12, 18, and 21 months of age in SHR without HF and in SHR with HF. Results were compared with those of age-matched normortensive Wistar-Kyoto (WKY) rats, and to untreated SHR with and without evidence of HF. ACEI initiated prior to failure prevented the changes in -MHC, ANF, pro-₁(III) collagen, and TGF-ß₁ gene expression that are associated with the transition to HF. ACEI initiated after the onset of HF lowered levels of TGF-ß₁ mRNA by 50% (P<.05) and elevated levels of -MHC mRNA two- to threefold (P<.05). Circulating levels of renin and angiotensin I were elevated four- to sixfold by ACEI, but surprisingly, plasma levels of angiotensin II were not reduced. ACEI increased LV renin mRNA levels in WKY and SHR by two- to threefold but did not influence LV levels of angiotensinogen mRNA. The results suggest that the anti-HF benefits of ACEI in SHR may be mediated, at least in part, by effects on the expression of specific genes, including those encoding -MHC, ANF, TGF-ß₁, pro-₁(III) collagen, and renin-angiotensin system components.

Key Words: angiotensin-converting enzyme inhibition • transforming growth factor-ß₁ • myosin heavy chain • myocardial hypertrophy and failure

This article has been cited by other articles:

				S. Pokharel, P. P. van Geel, U. C. Sharma, J. P.M. Cleutjens, H. Bohnemeier, X.-L. Tian, H. Schunkert, H. J.G.M. Crijns, M. Paul, and Y. M. Pinto Increased Myocardial Collagen Content in Transgenic Rats Overexpressing Cardiac Angiotensin-Converting Enzyme Is Related to Enhanced Breakdown of N-Acetyl-Ser-Asp-Lys-Pro and Increased Phosphorylation of Smad2/3 Circulation, November 9, 2004; 110(19): 3129 - 3135. [Abstract] [Full Text] [PDF]

				B. Schroen, S. Heymans, U. Sharma, W. M. Blankesteijn, S. Pokharel, J. P.M. Cleutjens, J. G. Porter, C. T.A. Evelo, R. Duisters, R. E.W. van Leeuwen, et al. Thrombospondin-2 Is Essential for Myocardial Matrix Integrity: Increased Expression Identifies Failure-Prone Cardiac Hypertrophy Circ. Res., September 3, 2004; 95(5): 515 - 522. [Abstract] [Full Text] [PDF]

				A. Scuteri, T. A. Manolio, E. K. Marino, A. M. Arnold, and E. G. Lakatta Prevalence of specific variant carotid geometric patterns and incidence of cardiovascular events in older persons: The cardiovascular health study (CHS E-131) J. Am. Coll. Cardiol., January 21, 2004; 43(2): 187 - 193. [Abstract] [Full Text] [PDF]

				S. Pokharel, S. Rasoul, A. J.M. Roks, R. E.W. van Leeuwen, M. J.A. van Luyn, L. E. Deelman, J. F. Smits, O. Carretero, W. H. van Gilst, and Y. M. Pinto N-Acetyl-Ser-Asp-Lys-Pro Inhibits Phosphorylation of Smad2 in Cardiac Fibroblasts Hypertension, August 1, 2002; 40(2): 155 - 161. [Abstract] [Full Text] [PDF]

				N.-E. Rhaleb, H. Peng, P. Harding, M. Tayeh, M. C. LaPointe, and O. A. Carretero Effect of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline on DNA and Collagen Synthesis in Rat Cardiac Fibroblasts Hypertension, March 1, 2001; 37(3): 827 - 832. [Abstract] [Full Text] [PDF]

				H. C. SCHRÖDER, A. KRASKO, R. BATEL, A. SKOROKHOD, S. PAHLER, M. KRUSE, I. M. MÜLLER, and W. E. G. MÜLLER Stimulation of protein (collagen) synthesis in sponge cells by a cardiac myotrophin-related molecule from Suberites domuncula FASEB J, October 1, 2000; 14(13): 2022 - 2031. [Abstract] [Full Text]

				W. W. Brooks, O. H. L. Bing, M. O. Boluyt, A. Malhotra, J. P. Morgan, N. Satoh, W. S. Colucci, and C. H. Conrad Altered Inotropic Responsiveness and Gene Expression of Hypertrophied Myocardium With Captopril Hypertension, June 1, 2000; 35(6): 1203 - 1209. [Abstract] [Full Text] [PDF]

				M. O. Boluyt and O. H.L. Bing Matrix gene expression and decompensated heart failure: The aged SHR model Cardiovasc Res, May 1, 2000; 46(2): 239 - 249. [Abstract] [Full Text] [PDF]

				H. Li, H. Simon, T. M.A. Bocan, and J.T. Peterson MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition Cardiovasc Res, May 1, 2000; 46(2): 298 - 306. [Abstract] [Full Text] [PDF]